Metraipolis › archive › dc_ffde09d8c70f

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system — Europe PMC PMID:40833961

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40833961
DOI
10.1371/journal.pone.0330493
License (as archived)
solo-consultazione
Archived
2026-11-10T11:50:53.542Z
SHA-256 of the archived text
d0b667ee354e8db3bb54de44057144e318853be4abeaf8e3000769fbb40ba241
Stable URL of this page
https://metraipolis.com/documento/dc_ffde09d8c70f

How to cite

Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system — Europe PMC PMID:40833961 — Europe PMC (en), https://europepmc.org/article/MED/40833961 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffde09d8c70f (Metraipolis archive dc_ffde09d8c70f, sha256 d0b667ee354e8db3bb54de44057144e318853be4abeaf8e3000769fbb40ba241)
BibTeX
@misc{dcffde09d8c70f,
  title = {Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system — Europe PMC PMID:40833961},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40833961},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffde09d8c70f; sha256 d0b667ee354e8db3bb54de44057144e318853be4abeaf8e3000769fbb40ba241},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40833961. Agents can read the archived copy with the MCP tool read_document.